|
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience Diabetologia (Browse Results) 26-03-2012 07:59 Abstract
Aims/hypothesis Fenofibrate has been noted to cause an elevation in serum creatinine in some individuals. Participants in the Action to Control
Cardiovascular Risk in Diabetes Lipid Study were studied to better characterise who is at risk of an increase in creatinine
level and to determine whether those with creatinine elevation have a differential risk of adverse renal or cardiovascular
outcomes.
Methods A fenofibrate-associated creatinine increase (FACI) was defined as an increase in serum creatinine of at least 20% from baseline
to month 4 in participants assigned to fenofibrate. Baseline patient characteristics, and baseline and 4-month drug, clinical,
laboratory... Read more... |
|
Soluble CD163: a biomarker linking macrophages and insulin resistance Diabetologia (Browse Results) 26-03-2012 07:59 Abstract
Aims/hypothesis Soluble CD163 (sCD163) was recently identified as a strong risk marker for developing type 2 diabetes. We hypothesised that
sCD163 independently associates with insulin resistance.
Methods This cross-sectional study includes 234 participants: 96 with type 2 diabetes, 34 with impaired glucose tolerance (IGT) and
104 with normal glucose tolerance (NGT), matched for sex and BMI. Glucose-lowering medication was paused for 1 week before
plasma samples were obtained for determination of sCD163 and other inflammatory and metabolic variables. Insulin resistance
was estimated by homeostasis model assessment of insulin resistance (HOMA-IR).
Results Concentrations of sCD163 were... Read more... |
|
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk Diabetologia (Browse Results) 22-03-2012 22:08 Abstract
Aims/hypothesis The aim of the study was to investigate the timing of the appearance of autoantibodies associated with type 1 diabetes between
birth and puberty, the natural fate of these autoantibodies and the predictive power of autoantibody concentrations for early
progression to clinical diabetes.
Methods Children were recruited to the Type 1 Diabetes Prediction and Prevention Project, an ongoing study based on HLA-conferred
genetic risk. Autoantibodies against islet cells, insulin, GAD65 and islet antigen 2 were analysed at 3–12 month intervals,
starting from birth.
Results During the follow-up, 1,320 children (18.4% of the cohort of... Read more... |
|
Intrapancreatic delivery of human umbilical cord blood aldehyde dehydrogenase-producing cells promotes islet regeneration Diabetologia (Browse Results) 20-03-2012 22:16 Abstract
Aims/hypothesis We sought to investigate the stimulation of islet regeneration by transplanted human umbilical cord blood (UCB) cells purified
according to high aldehyde dehydrogenase (ALDH) activity (ALDHhi), a conserved characteristic of multiple progenitor lineages. We hypothesised that direct intrapancreatic (iPan) delivery
of ALDHhi progenitors would augment islet regeneration via timely and localised exposure to islet-regenerative stimuli.
Methods Cells were purified from UCB based on flow cytometry for low ALDH activity (ALDHlo) vs ALDHhi. UCB ALDHlo or ALDHhi cells were compared for surface marker expression, as well as haematopoietic, endothelial and multipotent stromal progenitor
content in vitro. UCB... Read more... |
|
Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions Diabetologia (Browse Results) 20-03-2012 08:52 Abstract
Aims/hypothesis Impaired insulin sensitivity is a major factor leading to type 2 diabetes. Animal studies suggest that the brain is involved
in the regulation of insulin sensitivity. We investigated whether insulin action in the human brain regulates peripheral insulin
sensitivity and examined which brain areas are involved.
Methods Insulin and placebo were given intranasally. Plasma glucose, insulin and C-peptide were measured in 103 participants at 0,
30 and 60 min. A subgroup (n = 12) was also studied with functional MRI, and blood sampling at 0, 30 and 120 min. For each time-point, the HOMA of insulin
resistance (HOMA-IR) was calculated... Read more... |